Report Detail
Global Intravenous Immunoglobulin (IVIg) Market Growth 2019-2024
- RnM2996495 |
- 21 February, 2019 |
- Global |
- 167 Pages |
- LPI(LP Information) |
- Pharma & Healthcare
Intravenous Immunoglobulin, also called gamma globulin or antibodies, is a highly purified blood product preparation that is derived from large pools of plasma donors. Plasma from approximately 1,000 to 10,000 persons is present in each unit or “lot” of Intravenous Immunoglobulin.
North America region is the largest supplier of intravenous immunoglobulin (IVIg), with a production market share nearly 48% in 2016. Europe is the second largest supplier of intravenous immunoglobulin (IVIg), enjoying production market share nearly 23% in 2016.
North America is the largest sales place, with a sales market share nearly 44% in 2016. Following North America, Europe is the second largest sales place with the sales market share of 22%.
Market competition is intense. Baxter, Grifols, CSL, Octapharma, Biotest, Kedrion, etc. are the leaders of the industry, and they hold key technologies and patents, with high-end customers; have been formed in the monopoly position in the industry.
According to this study, over the next five years the Intravenous Immunoglobulin (IVIg) market will register a 6.0% CAGR in terms of revenue, the global market size will reach US$ 11500 million by 2024, from US$ 8120 million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Intravenous Immunoglobulin (IVIg) business, shared in Chapter 3.
This report presents a comprehensive overview, market shares, and growth opportunities of Intravenous Immunoglobulin (IVIg) market by product type, application, key manufacturers and key regions and countries.
This study considers the Intravenous Immunoglobulin (IVIg) value and volume generated from the sales of the following segments:
Segmentation by product type: breakdown data from 2014 to 2019, in Section 2.3; and forecast to 2024 in section 11.7.
IVIg Liquid
IVIg Powder
Segmentation by application: breakdown data from 2014 to 2019, in Section 2.4; and forecast to 2024 in section 11.8.
Immunodeficiency
Autoimmune Disease
Acute Infection
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Spain
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
Baxter
Grifols
CSL
Octapharma
Biotest
Kedrion
Hualan Bio
CNBG
Shanghai RAAS
CBPO
LFB Group
BPL
Sichuan Yuanda Shuyang
In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.
Research objectives
To study and analyze the global Intravenous Immunoglobulin (IVIg) consumption (value & volume) by key regions/countries, product type and application, history data from 2014 to 2018, and forecast to 2024.
To understand the structure of Intravenous Immunoglobulin (IVIg) market by identifying its various subsegments.
Focuses on the key global Intravenous Immunoglobulin (IVIg) manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Intravenous Immunoglobulin (IVIg) with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the consumption of Intravenous Immunoglobulin (IVIg) submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.
Table of Contents
2019-2024 Global Intravenous Immunoglobulin (IVIg) Consumption Market Report
1 Scope of the Report
- 1.1 Market Introduction
- 1.2 Research Objectives
- 1.3 Years Considered
- 1.4 Market Research Methodology
- 1.5 Economic Indicators
- 1.6 Currency Considered
2 Executive Summary
- 2.1 World Market Overview
- 2.1.1 Global Intravenous Immunoglobulin (IVIg) Consumption 2014-2024
- 2.1.2 Intravenous Immunoglobulin (IVIg) Consumption CAGR by Region
- 2.2 Intravenous Immunoglobulin (IVIg) Segment by Type
- 2.2.1 IVIg Liquid
- 2.2.2 IVIg Powder
- 2.3 Intravenous Immunoglobulin (IVIg) Consumption by Type
- 2.3.1 Global Intravenous Immunoglobulin (IVIg) Consumption Market Share by Type (2014-2019)
- 2.3.2 Global Intravenous Immunoglobulin (IVIg) Revenue and Market Share by Type (2014-2019)
- 2.3.3 Global Intravenous Immunoglobulin (IVIg) Sale Price by Type (2014-2019)
- 2.4 Intravenous Immunoglobulin (IVIg) Segment by Application
- 2.4.1 Immunodeficiency
- 2.4.2 Autoimmune Disease
- 2.4.3 Acute Infection
- 2.5 Intravenous Immunoglobulin (IVIg) Consumption by Application
- 2.5.1 Global Intravenous Immunoglobulin (IVIg) Consumption Market Share by Application (2014-2019)
- 2.5.2 Global Intravenous Immunoglobulin (IVIg) Value and Market Share by Application (2014-2019)
- 2.5.3 Global Intravenous Immunoglobulin (IVIg) Sale Price by Application (2014-2019)
3 Global Intravenous Immunoglobulin (IVIg) by Players
- 3.1 Global Intravenous Immunoglobulin (IVIg) Sales Market Share by Players
- 3.1.1 Global Intravenous Immunoglobulin (IVIg) Sales by Players (2017-2019)
- 3.1.2 Global Intravenous Immunoglobulin (IVIg) Sales Market Share by Players (2017-2019)
- 3.2 Global Intravenous Immunoglobulin (IVIg) Revenue Market Share by Players
- 3.2.1 Global Intravenous Immunoglobulin (IVIg) Revenue by Players (2017-2019)
- 3.2.2 Global Intravenous Immunoglobulin (IVIg) Revenue Market Share by Players (2017-2019)
- 3.3 Global Intravenous Immunoglobulin (IVIg) Sale Price by Players
- 3.4 Global Intravenous Immunoglobulin (IVIg) Manufacturing Base Distribution, Sales Area, Product Types by Players
- 3.4.1 Global Intravenous Immunoglobulin (IVIg) Manufacturing Base Distribution and Sales Area by Players
- 3.4.2 Players Intravenous Immunoglobulin (IVIg) Products Offered
- 3.5 Market Concentration Rate Analysis
- 3.5.1 Competition Landscape Analysis
- 3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
- 3.6 New Products and Potential Entrants
- 3.7 Mergers & Acquisitions, Expansion
4 Intravenous Immunoglobulin (IVIg) by Regions
- 4.1 Intravenous Immunoglobulin (IVIg) by Regions
- 4.1.1 Global Intravenous Immunoglobulin (IVIg) Consumption by Regions
- 4.1.2 Global Intravenous Immunoglobulin (IVIg) Value by Regions
- 4.2 Americas Intravenous Immunoglobulin (IVIg) Consumption Growth
- 4.3 APAC Intravenous Immunoglobulin (IVIg) Consumption Growth
- 4.4 Europe Intravenous Immunoglobulin (IVIg) Consumption Growth
- 4.5 Middle East & Africa Intravenous Immunoglobulin (IVIg) Consumption Growth
5 Americas
- 5.1 Americas Intravenous Immunoglobulin (IVIg) Consumption by Countries
- 5.1.1 Americas Intravenous Immunoglobulin (IVIg) Consumption by Countries (2014-2019)
- 5.1.2 Americas Intravenous Immunoglobulin (IVIg) Value by Countries (2014-2019)
- 5.2 Americas Intravenous Immunoglobulin (IVIg) Consumption by Type
- 5.3 Americas Intravenous Immunoglobulin (IVIg) Consumption by Application
- 5.4 United States
- 5.5 Canada
- 5.6 Mexico
- 5.7 Key Economic Indicators of Few Americas Countries
6 APAC
- 6.1 APAC Intravenous Immunoglobulin (IVIg) Consumption by Countries
- 6.1.1 APAC Intravenous Immunoglobulin (IVIg) Consumption by Countries (2014-2019)
- 6.1.2 APAC Intravenous Immunoglobulin (IVIg) Value by Countries (2014-2019)
- 6.2 APAC Intravenous Immunoglobulin (IVIg) Consumption by Type
- 6.3 APAC Intravenous Immunoglobulin (IVIg) Consumption by Application
- 6.4 China
- 6.5 Japan
- 6.6 Korea
- 6.7 Southeast Asia
- 6.8 India
- 6.9 Australia
- 6.10 Key Economic Indicators of Few APAC Countries
7 Europe
- 7.1 Europe Intravenous Immunoglobulin (IVIg) by Countries
- 7.1.1 Europe Intravenous Immunoglobulin (IVIg) Consumption by Countries (2014-2019)
- 7.1.2 Europe Intravenous Immunoglobulin (IVIg) Value by Countries (2014-2019)
- 7.2 Europe Intravenous Immunoglobulin (IVIg) Consumption by Type
- 7.3 Europe Intravenous Immunoglobulin (IVIg) Consumption by Application
- 7.4 Germany
- 7.5 France
- 7.6 UK
- 7.7 Italy
- 7.8 Russia
- 7.9 Spain
- 7.10 Key Economic Indicators of Few Europe Countries
8 Middle East & Africa
- 8.1 Middle East & Africa Intravenous Immunoglobulin (IVIg) by Countries
- 8.1.1 Middle East & Africa Intravenous Immunoglobulin (IVIg) Consumption by Countries (2014-2019)
- 8.1.2 Middle East & Africa Intravenous Immunoglobulin (IVIg) Value by Countries (2014-2019)
- 8.2 Middle East & Africa Intravenous Immunoglobulin (IVIg) Consumption by Type
- 8.3 Middle East & Africa Intravenous Immunoglobulin (IVIg) Consumption by Application
- 8.4 Egypt
- 8.5 South Africa
- 8.6 Israel
- 8.7 Turkey
- 8.8 GCC Countries
9 Market Drivers, Challenges and Trends
- 9.1 Market Drivers and Impact
- 9.1.1 Growing Demand from Key Regions
- 9.1.2 Growing Demand from Key Applications and Potential Industries
- 9.2 Market Challenges and Impact
- 9.3 Market Trends
10 Marketing, Distributors and Customer
- 10.1 Sales Channel
- 10.1.1 Direct Channels
- 10.1.2 Indirect Channels
- 10.2 Intravenous Immunoglobulin (IVIg) Distributors
- 10.3 Intravenous Immunoglobulin (IVIg) Customer
11 Global Intravenous Immunoglobulin (IVIg) Market Forecast
- 11.1 Global Intravenous Immunoglobulin (IVIg) Consumption Forecast (2019-2024)
- 11.2 Global Intravenous Immunoglobulin (IVIg) Forecast by Regions
- 11.2.1 Global Intravenous Immunoglobulin (IVIg) Forecast by Regions (2019-2024)
- 11.2.2 Global Intravenous Immunoglobulin (IVIg) Value Forecast by Regions (2019-2024)
- 11.2.3 Americas Consumption Forecast
- 11.2.4 APAC Consumption Forecast
- 11.2.5 Europe Consumption Forecast
- 11.2.6 Middle East & Africa Consumption Forecast
- 11.3 Americas Forecast by Countries
- 11.3.1 United States Market Forecast
- 11.3.2 Canada Market Forecast
- 11.3.3 Mexico Market Forecast
- 11.3.4 Brazil Market Forecast
- 11.4 APAC Forecast by Countries
- 11.4.1 China Market Forecast
- 11.4.2 Japan Market Forecast
- 11.4.3 Korea Market Forecast
- 11.4.4 Southeast Asia Market Forecast
- 11.4.5 India Market Forecast
- 11.4.6 Australia Market Forecast
- 11.5 Europe Forecast by Countries
- 11.5.1 Germany Market Forecast
- 11.5.2 France Market Forecast
- 11.5.3 UK Market Forecast
- 11.5.4 Italy Market Forecast
- 11.5.5 Russia Market Forecast
- 11.5.6 Spain Market Forecast
- 11.6 Middle East & Africa Forecast by Countries
- 11.6.1 Egypt Market Forecast
- 11.6.2 South Africa Market Forecast
- 11.6.3 Israel Market Forecast
- 11.6.4 Turkey Market Forecast
- 11.6.5 GCC Countries Market Forecast
- 11.7 Global Intravenous Immunoglobulin (IVIg) Forecast by Type
- 11.8 Global Intravenous Immunoglobulin (IVIg) Forecast by Application
12 Key Players Analysis
- 12.1 Baxter
- 12.1.1 Company Details
- 12.1.2 Intravenous Immunoglobulin (IVIg) Product Offered
- 12.1.3 Baxter Intravenous Immunoglobulin (IVIg) Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.1.4 Main Business Overview
- 12.1.5 Baxter News
- 12.2 Grifols
- 12.2.1 Company Details
- 12.2.2 Intravenous Immunoglobulin (IVIg) Product Offered
- 12.2.3 Grifols Intravenous Immunoglobulin (IVIg) Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.2.4 Main Business Overview
- 12.2.5 Grifols News
- 12.3 CSL
- 12.3.1 Company Details
- 12.3.2 Intravenous Immunoglobulin (IVIg) Product Offered
- 12.3.3 CSL Intravenous Immunoglobulin (IVIg) Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.3.4 Main Business Overview
- 12.3.5 CSL News
- 12.4 Octapharma
- 12.4.1 Company Details
- 12.4.2 Intravenous Immunoglobulin (IVIg) Product Offered
- 12.4.3 Octapharma Intravenous Immunoglobulin (IVIg) Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.4.4 Main Business Overview
- 12.4.5 Octapharma News
- 12.5 Biotest
- 12.5.1 Company Details
- 12.5.2 Intravenous Immunoglobulin (IVIg) Product Offered
- 12.5.3 Biotest Intravenous Immunoglobulin (IVIg) Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.5.4 Main Business Overview
- 12.5.5 Biotest News
- 12.6 Kedrion
- 12.6.1 Company Details
- 12.6.2 Intravenous Immunoglobulin (IVIg) Product Offered
- 12.6.3 Kedrion Intravenous Immunoglobulin (IVIg) Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.6.4 Main Business Overview
- 12.6.5 Kedrion News
- 12.7 Hualan Bio
- 12.7.1 Company Details
- 12.7.2 Intravenous Immunoglobulin (IVIg) Product Offered
- 12.7.3 Hualan Bio Intravenous Immunoglobulin (IVIg) Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.7.4 Main Business Overview
- 12.7.5 Hualan Bio News
- 12.8 CNBG
- 12.8.1 Company Details
- 12.8.2 Intravenous Immunoglobulin (IVIg) Product Offered
- 12.8.3 CNBG Intravenous Immunoglobulin (IVIg) Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.8.4 Main Business Overview
- 12.8.5 CNBG News
- 12.9 Shanghai RAAS
- 12.9.1 Company Details
- 12.9.2 Intravenous Immunoglobulin (IVIg) Product Offered
- 12.9.3 Shanghai RAAS Intravenous Immunoglobulin (IVIg) Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.9.4 Main Business Overview
- 12.9.5 Shanghai RAAS News
- 12.10 CBPO
- 12.10.1 Company Details
- 12.10.2 Intravenous Immunoglobulin (IVIg) Product Offered
- 12.10.3 CBPO Intravenous Immunoglobulin (IVIg) Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.10.4 Main Business Overview
- 12.10.5 CBPO News
- 12.11 LFB Group
- 12.12 BPL
- 12.13 Sichuan Yuanda Shuyang
13 Research Findings and Conclusion
Summary:
Get latest Market Research Reports on Intravenous Immunoglobulin (IVIg) . Industry analysis & Market Report on Intravenous Immunoglobulin (IVIg) is a syndicated market report, published as Global Intravenous Immunoglobulin (IVIg) Market Growth 2019-2024. It is complete Research Study and Industry Analysis of Intravenous Immunoglobulin (IVIg) market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
